VEEDA CR, India's fastest growing Clinical Research Organisation (CRO), today opened it's new Clinical Pharmacology Unit (CPU) at Muljibhai Patel Urological Hospital (MPUH), Nadiad, Gujarat. The unit was inaugurated by Mr. Dinsha J. Patel, Minister of State for Petroleum & Natural Gas & Dr. Nilima Kshirsagar (Director Professor, Infectious Diseases & Interdisciplinary Research, Maharashtra University of Health Sciences). Veeda will conduct Phase I /II clinical studies in Renal Impaired Patients, at the Unit.

Dr. Kiran Marthak, Director - Veeda CR said, "Conducting Phase I studies on renal impaired patients is highly important as many drugs are excreted by the body via the kidneys and a knowledge of the influence of kidney function on drug metabolism is essential to drug development. Veeda Clinical Research is very proud to become the first ever CRO to establish a specialized renal CPU in India. Veeda would also utilize this unit for carrying out Clinical Trials related to Urology like Ca Prostate and Ca Bladder which may necessitate admission in the ward which is in the hospital and immediately adjacent to the intensive care Unit The Unit has six fully monitored beds and all the supporting facilities necessary for the safe conduct of clinical trials in this special population. Working in this hospital gives us access to the full spectrum of patients with impaired kidney function from the mildest to the most severe"

Veeda CR has access to the experienced manpower of the hospital as well as the facilities available like Kidney Dialysis Machines, Pathology Laboratory, X-rays and CT scan.

Studies involving renal impaired patients are particularly important for newly discovered drugs for which the way in which the body handles the drug is not known.

The Veeda CR service blends 20 years of phase I expertise in UK and Germany with the substantial benefits, both intellectual and economic, of the Indian sub Continent. With the acquisition of DICE, a highly specialised data management CRO in Brussels, Veeda CR is well placed to deliver cost effective, timely research solutions to the pharmaceutical and biotechnology industries worldwide.

Veeda CR is capable of handling ail types of phase I and BA/BE studies-from technically complex trials to the more routine PK studies. We have a dedicated clinical pathology, bioanalysis, biomarker and immunogenicity laboratory which is GLP accredited. We have access to populations of patients, both treated and treatment-naive, as well as diabetics, hypertensive and asthmatic patients and also have unrivalled access to subjects with various cancers, renal impairment and cardiovascular conditions.